Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Harvard Apparatus Regenerative Technology, Inc.BSTG · Entity 7501 | Vice President of Finance | May 14, 2020 | May 15, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Harvard Apparatus Regenerative Technology, Inc.
Report date May 14, 2020 · Filed May 15, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,793 |
Ending reported balance
After 2020-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-05-14 · Grant · Acquired 10,000 · Balance 26,638 F1: Represents a stock award required to be granted under the Offer Letter between the Issuer and the Reporting Person. Row 2 · 2020-05-14 · Tax withholding · Disposed 2,845 · Balance 23,793 F2: The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the stock award granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a stock award required to be granted under the Offer Letter between the Issuer and the Reporting Person.
F2: The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the stock award granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2020 Filed May 15, 2020 16:07 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | Tax withholdingCommon Stock | 2,845 | $3.13 | $8,904.85 |
DisclosureSEC source: 0001104659-20-062594 · tm2019970-1_4.xml · nonDerivative · entry 2 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,793 F2 · shares: The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the stock award granted to the Reporting Person. Read SEC document |
| May 14, 2020 Filed May 15, 2020 16:07 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-062594 · tm2019970-1_4.xml · nonDerivative · entry 1 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,638 F1 · shares: Represents a stock award required to be granted under the Offer Letter between the Issuer and the Reporting Person. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 21:04 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | Tax withholdingCommon Stock | 3,157 | $3.05 | $9,628.85 |
DisclosureSEC source: 0001104659-20-053775 · tm2018172d1_4.xml · nonDerivative · entry 2 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,638 F2 · shares: The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the stock award granted to the Reporting Person. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 21:04 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-053775 · tm2018172d1_4.xml · nonDerivative · entry 1 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,795 F1 · shares: Represents a stock award required to be granted under the Offer Letter between the Issuer and the Reporting Person. Read SEC document |
| March 27, 2020 Filed Apr 2, 2020 11:39 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | Tax withholdingCommon Stock | 5,205 | $4.00 | $20,820.00 |
DisclosureSEC source: 0001104659-20-042283 · tm2014758d1_4.xml · nonDerivative · entry 2 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,795 F2 · shares: The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the stock award granted to the Reporting Person. Read SEC document |
| March 27, 2020 Filed Apr 2, 2020 11:39 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-042283 · tm2014758d1_4.xml · nonDerivative · entry 1 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Represents a stock award required to be granted under the Offer Letter between the Issuer and the Reporting Person. Read SEC document |
| March 24, 2020 Filed Mar 26, 2020 18:06 UTC | Harvard Apparatus Regenerative Technology, Inc. BSTG · Entity 7501 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001104659-20-038937 · tm2013962d2_4.xml · derivative · entry 1 CHAKOUTIS PETER M · CIK 0001257798 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock, par value $0.01 per share · 40,000 shares Expires 2030-03-24 F1 · derivative.exercise_date: This stock option vests as follows: (i) one quarter upon timely filing of the Company's Quarterly Report on Form 10-Q for the fiscal quarter ending March 31, 2020, and (ii) the remainder in twelve (12) equal quarterly increments on the first day of each calendar quarter starting with the first calendar quarter following the timely filing of such Form 10-Q. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.